Mean cost of bringing new drug to US market Is $879.3 million
Jul 02, 2024
R&D has remained relatively stable among large pharma companies despite a 27.3% growth in sales.
‘Smart’ pillbox won’t let seniors or their caregivers forget their daily doses, company promises
By
Aaron Dorman
Dec 12, 2023
A new “smart” pillbox system can help older adults, their families and their caregivers coordinate to maintain proper medication regimens.
10 percent of new drugs approved without meeting primary efficacy end points
Feb 14, 2023
The findings were seen for 21 drug approvals between 2018 and 2021, with only one-third needing postmarketing studies.
Timing of blood pressure meds has no impact on outcomes
By
Haymarket Media
Sep 10, 2024
The findings were seen for both primary care patients with hypertension and nursing home residents.
Is Eli Lilly using ‘granfluencers’ to raise awareness of its Alzheimer’s med?
By
Marc Iskowitz
Sep 04, 2024
Here’s why older internet celebs — granfluencers — soon might be making rounds on the Alzheimer’s drug marketing scene.
Risk for dementia similar with SGLT2 inhibitors, dulaglutide in T2DM
Aug 26, 2024
The estimated risk difference varied from −2.45 to 0.63 percentage points with SGLT2 versus dulaglutide among older adults.
Semaglutide-linked suicidal ideation ID’d in disproportionality analysis
Aug 21, 2024
Significant disproportionality was detected for semaglutide-associated suicidal ideation as an adverse drug reaction.
Pandemic challenges raise concerns about assisted living’s ability to care for cognitively impaired...
By
Kimberly Bonvissuto
Aug 15, 2024
Exacerbated challenges faced by memory care assisted living communities during the COVID-19 pandemic may have contributed to the increased use of antipsychotics and antidepressants, raising concerns about...
Commonly prescribed antibiotics linked to cutaneous adverse drug reactions
Aug 12, 2024
Sulfonamide antibiotics and cephalosporins are most strongly associated with serious cADRs relative to macrolides.
PREVENT equations reclassify half of US adults to lower ASCVD risk
Aug 02, 2024
A considerable decrease was estimated in US adults receiving or recommended for preventive treatment with statins and antihypertensives.